Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Exchange Rate Effect: 2010-2024

Historic Exchange Rate Effect for Lineage Cell Therapeutics (LCTX) over the last 15 years, with Dec 2024 value amounting to -$95,000.

  • Lineage Cell Therapeutics' Exchange Rate Effect fell 110.53% to -$4,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $241,000, marking a year-over-year increase of 48.77%. This contributed to the annual value of -$95,000 for FY2024, which is 62.00% up from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Exchange Rate Effect of -$95,000 as of FY2024, which was up 62.00% from -$250,000 recorded in FY2023.
  • In the past 5 years, Lineage Cell Therapeutics' Exchange Rate Effect ranged from a high of -$20,000 in FY2021 and a low of -$873,000 during FY2022.
  • Over the past 3 years, Lineage Cell Therapeutics' median Exchange Rate Effect value was -$250,000 (recorded in 2023), while the average stood at -$406,000.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 4,265.00% in 2022, then skyrocketed by 71.36% in 2023.
  • Over the past 5 years, Lineage Cell Therapeutics' Exchange Rate Effect (Yearly) stood at -$63,000 in 2020, then surged by 68.25% to -$20,000 in 2021, then crashed by 4,265.00% to -$873,000 in 2022, then surged by 71.36% to -$250,000 in 2023, then spiked by 62.00% to -$95,000 in 2024.